Back to search

Preclinical evaluation of illudins as anticancer agents.

Data up to Jan 2025

Published1987
Citations116
References14

Total Citations Per Year

Abstract

References (14)

Establishment and identification of small cell lung cancer cell lines having classic and variant features

1986 • 896 citations

Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.

1979 • 478 citations

Application of a human tumor colony-forming assay to new drug screening.

1985 • 217 citations

Antibiotic Substances from Basidiomycetes

1950 • 102 citations

Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.

1986 • 96 citations

Preclinical drug development: rationale and methods.

1981 • 92 citations

The Structures of the Basidiomycete Metabolites Illudin S and Illudin M

1963 • 91 citations

Effects of anti‐transferrin receptor antibodies on growth of normal and malignant myeloid cells

1983 • 82 citations

The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.

1983 • 51 citations

Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation

1985 • 36 citations

KB Cell Culture. I. Role in Discovery of Antitumor Agents From Higher Plants

1982 • 28 citations

Use of nude mouse xenografts as preclinical drug screens: Further studies onin vitro growth of xenograft tumor colony-forming cells

1986 • 18 citations

In vitro drug testing using hemopoietic cells: Goals and limitations

1985 • 10 citations

Csf‐responsive bone marrow cells in liquid culture: Characterization and screening applications

1986 • 6 citations

Cited By (0)

Loading...
Preclinical evaluation of illudins as anticancer agents. (1987) – PubMed | Metascience Observatory Explorer